Merck Pre-Tax Income 2010-2024 | MKKGY

Merck annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Merck pre-tax income for the quarter ending June 30, 2024 was $0.845B, a 13.28% decline year-over-year.
  • Merck pre-tax income for the twelve months ending June 30, 2024 was $3.531B, a 14% decline year-over-year.
  • Merck annual pre-tax income for 2023 was $3.771B, a 16.52% decline from 2022.
  • Merck annual pre-tax income for 2022 was $4.517B, a 2.71% decline from 2021.
  • Merck annual pre-tax income for 2021 was $4.642B, a 54.53% increase from 2020.
Merck Annual Pre-Tax Income
(Millions of US $)
2023 $3,771
2022 $4,517
2021 $4,642
2020 $3,004
2019 $1,943
2018 $1,725
2017 $2,514
2016 $2,384
2015 $1,650
2014 $2,070
2013 $1,844
2012 $912
2011 $1,186
2010 $12,338
2009 $10,807
Merck Quarterly Pre-Tax Income
(Millions of US $)
2024-06-30 $845
2024-03-31 $976
2023-12-31 $690
2023-09-30 $1,020
2023-06-30 $975
2023-03-31 $1,086
2022-12-31 $849
2022-09-30 $1,196
2022-06-30 $1,194
2022-03-31 $1,278
2021-12-31 $1,135
2021-09-30 $1,171
2021-06-30 $1,151
2021-03-31 $1,186
2020-12-31 $650
2020-09-30 $1,245
2020-06-30 $428
2020-03-31 $681
2019-12-31 $489
2019-09-30 $526
2019-06-30 $627
2019-03-31 $302
2018-12-31 $268
2018-09-30 $506
2018-06-30 $391
2018-03-31 $561
2017-12-31 $190
2017-09-30 $983
2017-06-30 $613
2017-03-31 $729
2016-12-31 $359
2016-09-30 $680
2016-06-30 $485
2016-03-31 $860
2015-12-31 $175
2015-09-30 $537
2015-06-30 $509
2015-03-31 $428
2014-12-31 $446
2014-09-30 $493
2014-06-30 $536
2014-03-31 $594
2013-12-31 $280
2013-09-30 $570
2013-06-30 $544
2013-03-31 $450
2012-12-31 $3,646
2012-09-30 $325
2012-06-30 $-60
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $-140
2011-03-31 $3,505
2010-12-31 $6,479
2010-09-30 $373
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00